Rommasi, F., Nasiri, M. J., & Mirsaeidi, M. (2022). Immunomodulatory agents for COVID-19 treatment: Possible mechanism of action and immunopathology features. Molecular and cellular biochemistry, 477(3), 711-726. https://doi.org/10.1007/s11010-021-04325-9
Chicago Style (17th ed.) CitationRommasi, Foad, Mohammad Javad Nasiri, and Mehdi Mirsaeidi. "Immunomodulatory Agents for COVID-19 Treatment: Possible Mechanism of Action and Immunopathology Features." Molecular and Cellular Biochemistry 477, no. 3 (2022): 711-726. https://doi.org/10.1007/s11010-021-04325-9.
MLA (9th ed.) CitationRommasi, Foad, et al. "Immunomodulatory Agents for COVID-19 Treatment: Possible Mechanism of Action and Immunopathology Features." Molecular and Cellular Biochemistry, vol. 477, no. 3, 2022, pp. 711-726, https://doi.org/10.1007/s11010-021-04325-9.